Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

ClinicalTrials.gov ID: NCT00032487

Public ClinicalTrials.gov record NCT00032487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 2:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CSP #465 - Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a prospective, 2-arm, randomized controlled trial to determine whether glycemic control, achieved through intensification of treatment, is effective in preventing clinical macrovascular complications in patients with type 2 DM who are no longer responsive to oral agents alone. The study consists of a two-year accrual period and five years of follow-up (7 years total) of 1700 patients across 20 centers. We have powered the study to detect a 21% reduction in the primary event rate. Additional study goals are to determine whether the expenditures, discomfort, and adverse effects associated with intensive intervention are justified in terms of their clinical benefits, considering both macrovascular and microvascular complications.

Study identification

NCT ID
NCT00032487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,791 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2000
Primary completion
May 29, 2008
Completion
May 29, 2008
Last update posted
Mar 29, 2017

2000 – 2008

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Carl T. Hayden VA Medical Center Phoenix Arizona 85012
Southern Arizona VA Health Care System, Tucson Tucson Arizona 85723
VA Central California Health Care System, Fresno Fresno California 93703
VA Medical Center, Long Beach Long Beach California 90822
VA San Diego Healthcare System, San Diego San Diego California 92161
Miami VA Healthcare System, Miami, FL Miami Florida 33125
Edward Hines, Jr. VA Hospital Hines Illinois 60141-5000
Richard Roudebush VA Medical Center, Indianapolis Indianapolis Indiana 46202-2884
VA Medical Center, Lexington Lexington Kentucky 40502
VA Medical Center, Minneapolis Minneapolis Minnesota 55417
VA Medical Center, Omaha Omaha Nebraska 68105-1873
VA New Jersey Health Care System, East Orange East Orange New Jersey 07018
VA Pittsburgh Health Care System Pittsburgh Pennsylvania 15240
Ralph H Johnson VA Medical Center, Charleston Charleston South Carolina 29401-5799
VA Medical Center Nashville Tennessee 37212-2637
Michael E. DeBakey VA Medical Center (152) Houston Texas 77030
VA South Texas Health Care System, San Antonio San Antonio Texas 78229
Hunter Holmes McGuire VA Medical Center Richmond Virginia 23249
VA Medical Center, Salem VA Salem Virginia 24153
VA Puget Sound Health Care System, Seattle Seattle Washington 98108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00032487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2017 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00032487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →